Leaflet MONOPOST 50mcg / ml ophthalmic drops solution

Product code:
W63388001
Quantity:
1
Indicated for:
glaucoma; ocular hypertension
Route of administration:
ophthalmic
Substance:
latanoprost (glaucoma agent)
ATC
S01EE01 — Sensory organs | Antiglaucoma preparations and miotics | Prostaglandin analogues
Latanoprost is a prostaglandin analog used for the treatment of open-angle glaucoma and ocular hypertension. It works by increasing the outflow of aqueous humor, thereby reducing intraocular pressure.

The medication is administered as eye drops, usually once daily in the evening. It is important to follow the doctor's instructions to achieve the best results.

Side effects may include eye irritation, redness, changes in iris color, or eyelash growth. In rare cases, allergic reactions or macular edema may occur.

Latanoprost is not recommended for patients with hypersensitivity to this medication or any of its components.

General data about MONOPOST 50mcg / ml

Substance:
latanoprost
Date of latest medicines list:
01-06-2017
Product code:
W63388001
Concentration:
50mcg / ml
Pharmaceutical form:
ophthalmic drops solution
Quantity:
1
Product type:
Generic medicine
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
DELPHARM TOURS - FRANTA
Holder:
LABORATOIRES THEA - FRANTA
Number:
14562/2022/01
Shelf life:
2 years-after packing for marketing;after the first opening-1 luna

Pharmaceutical forms available for latanoprost

Concentrations available for latanoprost

  • 0.005%
  • 0.05mg/ml
  • 50mcg/ml

Combinations with other substances